Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death Dis. 2017 12 14; 8(12):3217.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal
Antimetabolites, Antineoplastic
Antimetabolites, Antineoplastic
Azacitidine
Azacitidine
beta-Galactosidase
beta-Galactosidase
Cell Line, Tumor
Cell Line, Tumor
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinase Inhibitor p16
Epigenesis, Genetic
Epigenesis, Genetic
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Interleukin-6
Interleukin-6
Keratin-5
Keratin-5
Muscle, Smooth
Muscle, Smooth
Neoplasm Invasiveness
Neoplasm Invasiveness
Receptor, Notch1
Receptor, Notch1
Signal Transduction
Signal Transduction
Treatment Outcome
Treatment Outcome
Urinary Bladder Neoplasms
Urinary Bladder Neoplasms
authors with profiles
Lacey R McNally